Uploaded April 2025 | Updated September 2026, 2 weeks ago
Learn more about Dr. Mack Roach III here:
ucsfhealth.org/providers/dr-mack-roach-iii
0:47 Dr. Roach's opening remarks
1:47 Radiotherapy for localized prostate cancer
3:55 Disclosures
4:10 Radiation & surgery outcomes
8:00 Types of radiation
8:53 Past, present, & future of radiotherapy
11:44 Local salvage therapies after radiotherapy
15:00 Magnetic resonance vs. computed tomography study
19:41 Identical MR linacs with different margins
21:54 Factors that might impact toxicity
24:46 Hormone therapy before or after radiation?
26:31 Age and cancer-specific outcomes
29:14 Stereotactic body radiation and HDR brachytherapy
30:31 Delayed treatment
38:46 Who needs high-dose radiation?
41:32 AI models vs. genomic biomarkers
42:13 Race and prostate cancer
To learn more about prostate cancer, visit pcri.org
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Donate to PCRI: pcri.org/donate
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
#ElisabethHeathMD
Learn more about Dr. Mack Roach III here:
ucsfhealth.org/providers/dr-mack-roach-iii
0:47 Dr. Roach's opening remarks
1:47 Radiotherapy for localized prostate cancer
3:55 Disclosures
4:10 Radiation & surgery outcomes
8:00 Types of radiation
8:53 Past, present, & future of radiotherapy
11:44 Local salvage therapies after radiotherapy
15:00 Magnetic resonance vs. computed tomography study
19:41 Identical MR linacs with different margins
21:54 Factors that might impact toxicity
24:46 Hormone therapy before or after radiation?
26:31 Age and cancer-specific outcomes
29:14 Stereotactic body radiation and HDR brachytherapy
30:31 Delayed treatment
38:46 Who needs high-dose radiation?
41:32 AI models vs. genomic biomarkers
42:13 Race and prostate cancer
To learn more about prostate cancer, visit pcri.org
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Donate to PCRI: pcri.org/donate
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
#ElisabethHeathMD
